228 related articles for article (PubMed ID: 24112101)
1. Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.
Zhang D; Wang Y; Dong L; Huang Y; Yuan J; Ben W; Yang Y; Ning N; Lu M; Guan Y
Cancer Sci; 2013 Dec; 104(12):1690-6. PubMed ID: 24112101
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
3. EF24 Suppresses Invasion and Migration of Hepatocellular Carcinoma Cells
Zhao R; Tin L; Zhang Y; Wu Y; Jin Y; Jin X; Zhang F; Li X
Biomed Res Int; 2016; 2016():8569684. PubMed ID: 27999817
[TBL] [Abstract][Full Text] [Related]
4. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.
Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX
Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770
[TBL] [Abstract][Full Text] [Related]
5. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression.
Selvendiran K; Tong L; Vishwanath S; Bratasz A; Trigg NJ; Kutala VK; Hideg K; Kuppusamy P
J Biol Chem; 2007 Sep; 282(39):28609-28618. PubMed ID: 17684018
[TBL] [Abstract][Full Text] [Related]
6. The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis.
Duan Y; Chen HL; Ling M; Zhang S; Ma FX; Zhang HC; Lv XA
Mol Cell Biol; 2022 Jan; 42(1):e0016321. PubMed ID: 34780286
[TBL] [Abstract][Full Text] [Related]
7. miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
Guo H; Nan Y; Zhen Y; Zhang Y; Guo L; Yu K; Huang Q; Zhong Y
Tumour Biol; 2016 Oct; 37(10):13751-13761. PubMed ID: 27476171
[TBL] [Abstract][Full Text] [Related]
8. Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells.
Tan X; Sidell N; Mancini A; Huang RP; Shenming Wang ; Horowitz IR; Liotta DC; Taylor RN; Wieser F
Reprod Sci; 2010 Oct; 17(10):931-40. PubMed ID: 20693500
[TBL] [Abstract][Full Text] [Related]
9. EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1.
Thomas SL; Zhong D; Zhou W; Malik S; Liotta D; Snyder JP; Hamel E; Giannakakou P
Cell Cycle; 2008 Aug; 7(15):2409-17. PubMed ID: 18682687
[TBL] [Abstract][Full Text] [Related]
10. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.
Liu H; Liang Y; Wang L; Tian L; Song R; Han T; Pan S; Liu L
PLoS One; 2012; 7(10):e48075. PubMed ID: 23118928
[TBL] [Abstract][Full Text] [Related]
12. TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells.
Straus DS
Mol Cancer; 2013 Jul; 12():78. PubMed ID: 23866118
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
[TBL] [Abstract][Full Text] [Related]
14. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.
Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G
Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110
[TBL] [Abstract][Full Text] [Related]
15. Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy.
Thomas SL; Zhao J; Li Z; Lou B; Du Y; Purcell J; Snyder JP; Khuri FR; Liotta D; Fu H
Biochem Pharmacol; 2010 Nov; 80(9):1309-16. PubMed ID: 20615389
[TBL] [Abstract][Full Text] [Related]
16. Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic"
Bakalova R; Zhelev Z; Shibata S; Nikolova B; Aoki I; Higashi T
Anticancer Res; 2017 Oct; 37(10):5449-5458. PubMed ID: 28982855
[TBL] [Abstract][Full Text] [Related]
17. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
Yang CH; Yue J; Sims M; Pfeffer LM
PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.
Fan JY; Yang Y; Xie JY; Lu YL; Shi K; Huang YQ
Tumour Biol; 2016 May; 37(5):6855-60. PubMed ID: 26662316
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin.
Kasinski AL; Du Y; Thomas SL; Zhao J; Sun SY; Khuri FR; Wang CY; Shoji M; Sun A; Snyder JP; Liotta D; Fu H
Mol Pharmacol; 2008 Sep; 74(3):654-61. PubMed ID: 18577686
[TBL] [Abstract][Full Text] [Related]
20. Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch.
Chen L; Li Q; Zheng Z; Xie J; Lin X; Jiang C; Xu H; Wu X; Wu J; Zhang H
Chem Biol Drug Des; 2019 Jul; 94(1):1368-1377. PubMed ID: 30873716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
